china merchants securities

Innovent Biologics’ HK IPO sells long-term value

The drug developer will be the second biotech firm to list in Hong Kong without any profits or revenues. It believes that China’s underpenetrated biologics market provides a massive opportunity in the long run.
October 18, 2018

GRC Bank taps HK for equity financing

The regional Chinese lender launches an initial public offering to raise $1.1 billion and looks set to become the third bank classed as a rural financial institution to list in Hong Kong.
June 05, 2017

Wuxi AppTec joins biologics IPO rush

Chinese biopharmaceutical firm to list biologics arm in Hong Kong after delisting in New York in 2015. All the signs are it will deliver healthy returns for backers of its privatisation.
May 25, 2017

Datang Environment revives HK IPO

China Datang Group has launched a second attempt to spin-off its energy conservation business as China tightens emissions standards.
November 01, 2016